DCF P(above)=96.8%, FV=$194 vs price $134 — 45% upside. Below 200dma (headwind). Strong DCF signal, but price downtrend with no clear near-term catalyst for reversal. Good thesis potential: outsourced tech services, post-Ukraine rebuild optionality. Missing: identifiable catalyst to close the gap to fair value.
10-K FY2025 read. Organic revenue growth only 4.9% in 2025; 2026 guided at 3-6% organic — not re-accelerating. Non-GAAP margin compressing (16.5%→15.2%). GAAP earnings declined YoY. Still 14,100 staff in Ukraine/Belarus. Heavy M&A reliance (9.2% inorganic in 2025). Positives: fortress balance sheet (.3B cash, near-zero debt), aggressive buybacks (M in 2025 + M ASR), AI repositioning underway. At ~14x non-GAAP 2026 earnings the valuation is fair-ish but the organic growth story isn't there yet. Modest conviction — recovery is real but slow, execution risk remains elevated.
Fair Value Distribution — percentile bands
97.5% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-2.7%/yr
±4.3% · revenue growth to justify current price
FCF-Based Reverse DCF
4.0%/yr
±2.5% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~6h).
Eagle will generate this view by the next trading session (~6h).
FY2025: Revenue .46B (+15.4% reported, +4.9% organic constant currency). GAAP op margin compressed 11.5%→9.5%; Non-GAAP margin 16.5%→15.2%. Net income .7M (down from .5M). Cash .30B, near-zero debt. M...
EPAM: Quality tech services with AI growth thesis, but geopolitical+margin compression risks warrant caution. Diversified client base and excellent attrition are structural strengths.